Becton, dickinson and company:1106636 [17-048565]
Ended Awarded Last action
- Contract number
- HHSN26100051
- Awardee
-
Becton, Dickinson And Company UEI MM5ZHL8SRFY5 Part of Becton, Dickinson And Co
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $97,383
Award facts
- Opportunity
-
- N02RC4256357 Solicitation number
- Flow Cytometric Analysis of Benign and Malignant Tumors. Award Notice · Posted Jun 30, 2014
- Contract value 100% obligated
- $97,382.84 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
- Legislative mandates
-
- Clinger-Cohen Act FAR part 39
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$0 | |
| Original award | $97,383 |
About this award
This is a firm fixed-price delivery order awarded by the National Cancer Institute, a component of the National Institutes of Health, to Becton, Dickinson and Company (BD) for $97,382.84. The order is for flow cytometric analysis of benign and malignant tumors. BD Biosciences, a division of BD, is the awardee. The contract has no set-aside designation.
BD is a global medical technology company that develops, manufactures, and sells medical supplies, instruments, laboratory equipment, and diagnostic products. BD Biosciences focuses on providing instruments, reagents, and services that support biomedical research and clinical applications through flow cytometry, cell imaging, and genomics technologies. BD has extensive experience providing specialized equipment and consumables to support biomedical research and clinical programs for various federal agencies including the Department of Veterans Affairs, Department of Defense, and other health-related entities.
Quick answers
Who was awarded contract HHSN26100051?
HHSN26100051 was awarded to Becton, Dickinson And Company by National Cancer Institute (National Institutes of Health) on July 11, 2017.
How much is contract HHSN26100051 worth?
The government has obligated $97,383 on HHSN26100051.
Is contract HHSN26100051 an order under another contract?
Yes. HHSN26100051 is a delivery order under HHSN261201400013I, an indefinite delivery contract.
Was contract HHSN26100051 competed?
The extent of competition for HHSN26100051 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award